Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.
about
Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of LiteratureHistopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsGenomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFRThe quest to overcome resistance to EGFR-targeted therapies in cancer.Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureSmall-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer.Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationMechanisms of resistance to EGFR tyrosine kinase inhibitors.A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells.Mechanisms of resistance to EGFR targeted therapies.Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasisMutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.Large-cell neuroendocrine carcinoma of lung with epidermal growth factor receptor (EGFR) gene mutation and co-expression of adenocarcinoma markers: a case report and review of the literatureGenetic alterations and protein expression in combined small cell lung cancers and small cell lung cancers arising from lung adenocarcinomas after therapy with tyrosine kinase inhibitors.Epidermal growth factor receptor mutations in lung adenocarcinoma.Lineage factors and differentiation states in lung cancer progression.NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.Acquired resistance L747S mutation in an epidermal growth factor receptor-tyrosine kinase inhibitor-naïve patient: A report of three cases.The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer.Understanding and targeting resistance mechanisms in NSCLC.Small-cell transformation of ALK-rearranged non-small-cell adenocarcinoma of the lung.Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non-Small Cell Lung Cancer.Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung.
P2860
Q26766283-C51F384C-D103-42EE-9BD9-7729AE07A3FCQ28077504-70BDC2FA-952F-4B6E-AF96-A1EA91678F62Q28086993-B96D607D-320A-4A8B-AC0F-2E43F09A26B9Q33725976-2AE65FDB-3B9B-437C-8E99-61C894A5B501Q33925170-F605D352-9208-4DE1-A9AC-5A9C56E8138DQ34493031-AE3B18BD-DFE7-414C-AE18-15F852F626D4Q35164473-5F599D20-EF8E-4AFF-9033-17F29DB54317Q35196345-37E01516-0074-4CF7-A3A4-FC2271ADADADQ35875227-6C6EEC23-7F0B-45CA-97CB-6341FF2ADAA3Q36238664-D67A1346-1B8F-4386-8BF0-11CE6E217667Q36823866-BBF43F74-113A-4FB4-83F3-809D67A7954AQ36887721-A634C1BF-DB56-4772-9662-178AF2ED6291Q36971430-FA1F2840-C734-452A-9EFE-26E91FF9D595Q37051546-9569135A-E331-4C83-B9A9-A7986DFEAEFBQ37059866-B9BC1DE6-BBE2-403B-9C2D-182E30C1F009Q37376246-99BA18CE-DB9E-428E-A4F1-DCD3C5E3FFE5Q38174770-201374ED-361A-435B-B718-4B8D2DC03248Q38395972-B2379FE7-3326-48C5-8922-3973423BCB8DQ40198629-622ED388-5B73-4A30-B4C5-1039B431508FQ41852971-8E03B5CE-A508-4634-A07D-73E242389D3FQ42378535-4C2F47C1-2309-44A1-8B40-5DBB2327362FQ46915997-E495A640-C819-49DE-9C94-53997E084F47Q47215959-9239C796-1C69-44B5-B5AD-84EF93BA2290Q48354758-E5661C02-5911-4BF4-B29E-7561D1D080B5Q49887989-FF66FA14-0812-4F6F-8EB2-AAF17A237AFBQ51166938-62CF300E-F9E5-4A19-81E8-E9A8B40057B3Q54546470-883CAD85-0C4F-43C4-BC30-6577AFF3B132
P2860
Small-cell carcinoma with an epidermal growth factor receptor mutation in a never-smoker with gefitinib-responsive adenocarcinoma of the lung.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@ast
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@en
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@nl
type
label
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@ast
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@en
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@nl
prefLabel
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@ast
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@en
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@nl
P2093
P356
P1433
P1476
Small-cell carcinoma with an e ...... ve adenocarcinoma of the lung.
@en
P2093
Alexander M Truskinovsky
Arkadiusz Z Dudek
Atul Kapoor
Karen S Gustafson
Maureen F Zakowski
Naheed Alam
P356
10.3816/CLC.2010.N.046
P407
P50
P577
2010-09-01T00:00:00Z